The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 5,712 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 2,097 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 9,786 | 350,000 | SH | Put | SOLE | 350,000 | 0 | 0 | |
ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 1,930 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 407 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 5,684 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 653 | 46,622 | SH | SOLE | 46,622 | 0 | 0 | ||
ALCOBRA LTD | SHS | M2239P109 | 1,137 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 5,569 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 3,299 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 8,465 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 9,028 | 90,202 | SH | SOLE | 90,202 | 0 | 0 | ||
CHIASMA INC | COM | 16706W102 | 687 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 355 | 18,500 | SH | SOLE | 18,500 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 1,803 | 151,535 | SH | SOLE | 151,535 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 2,583 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 8,821 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
ENDO INTL PLC | SHS | G30401106 | 678 | 24,100 | SH | SOLE | 24,100 | 0 | 0 | ||
ENTELLUS MED INC | COM | 29363K105 | 2,001 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
GENMARK DIAGNOSTICS INC | COM | 372309104 | 1,581 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 475 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
HORIZON PHARMA PLC | SHS | G4617B105 | 7,042 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
INTEGRA LIFESCIENCES HLDGS C | COM NEW | 457985208 | 3,368 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 8,297 | 75,000 | SH | Put | SOLE | 75,000 | 0 | 0 | |
LION BIOTECHNOLOGIES INC | COM | 53619R102 | 1,270 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
MEDTRONIC PLC | COM | G5960L103 | 1,993 | 26,578 | SH | SOLE | 26,578 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 5,350 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 3,425 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 4,220 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 3,406 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
OCERA THERAPEUTICS INC | COM | 67552A108 | 132 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
OPHTHOTECH CORP | COM | 683745103 | 5,072 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 5,950 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 816 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 2,040 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
RESMED INC | COM | 761152107 | 2,891 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 5,130 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 11,037 | 220,000 | SH | Put | SOLE | 220,000 | 0 | 0 | |
SPECTRANETICS CORP | COM | 84760C107 | 5,082 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
ST JUDE MED INC | COM | 790849103 | 2,008 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 332 | 72,726 | SH | SOLE | 72,726 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM | 875372104 | 1,307 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | ADR | 881624209 | 5,351 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
ISHARES TR | U.S. MED DVC ETF | 464288810 | 3,062 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
ISHARES TR | U.S. PHARMA ETF | 464288836 | 1,342 | 9,800 | SH | SOLE | 9,800 | 0 | 0 | ||
ISHARES TR | US HLTHCR PR ETF | 464288828 | 4,818 | 39,500 | SH | SOLE | 39,500 | 0 | 0 | ||
VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 2,630 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
VERACYTE INC | COM | 92337F107 | 1,845 | 341,708 | SH | SOLE | 341,708 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 2,007 | 25,253 | SH | SOLE | 25,253 | 0 | 0 | ||
VITAE PHARMACEUTICALS INC | COM | 92847N103 | 671 | 101,188 | SH | SOLE | 101,188 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 2,075 | 125,000 | SH | SOLE | 125,000 | 0 | 0 |